Sintx Technologies (SINT) Income from Continuing Operations (2013 - 2026)
Sintx Technologies (SINT) posted quarterly Income from Continuing Operations of 2821000.0 for Q1 2026, down 23.08% year-over-year from 3667460.01 in Q1 2025, and down 27.36% quarter-over-quarter from 2215000.0 in Q4 2025.
Sintx Technologies (SINT) Income from Continuing Operations (2013 - 2026) Analysis & Trends
Sintx Technologies' Income from Continuing Operations history runs 14 years deep, the most recent figure standing at 2821000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 23.08% year-over-year to 2821000.0; the TTM figure through Mar 2026 stood at 10893000.0 (up 12.37% YoY), while the FY2025 annual figure was 8188000.0, up 21.34% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 2821000.0, down from 2215000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 293000.0 in Q1 2023, with the low at 6239000.0 in Q3 2024.
- The 5-year median for Income from Continuing Operations is 2455000.0 (2023), against an average of 2618058.82.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations surged 89.7% in 2023, then slumped 202.39% in 2024.
- Sintx Technologies' Income from Continuing Operations stood at 3958000.0 in 2022, then surged by 41.36% to 2321000.0 in 2023, then grew by 26.97% to 1695000.0 in 2024, then tumbled by 30.68% to 2215000.0 in 2025, then retreated by 27.36% to 2821000.0 in 2026.
- Business Quant data shows SINT's Income from Continuing Operations at 2821000.0 in Q1 2026, 2215000.0 in Q4 2025, and 3539000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Sintx Technologies | 7.61 Mn | 7.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.82 Mn |
| Dec 31, 2025 | -2.22 Mn |
| Sep 30, 2025 | -3.54 Mn |
| Jun 30, 2025 | -2.32 Mn |
| Mar 31, 2025 | -2.29 Mn |
| Dec 31, 2024 | -1.70 Mn |
| Sep 30, 2024 | -6.24 Mn |
| Jun 30, 2024 | -2.20 Mn |
| Mar 31, 2024 | -886,000.00 |
| Dec 31, 2023 | -2.32 Mn |
| Sep 30, 2023 | -3.19 Mn |
| Jun 30, 2023 | -2.46 Mn |
| Mar 31, 2023 | -293,000.00 |
| Dec 31, 2022 | -3.96 Mn |
| Sep 30, 2022 | -2.72 Mn |
| Jun 30, 2022 | -2.51 Mn |
| Mar 31, 2022 | -2.85 Mn |
| Dec 31, 2021 | -2.13 Mn |
| Sep 30, 2021 | -2.34 Mn |
| Jun 30, 2021 | -2.20 Mn |